{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:45:02Z","timestamp":1761561902728},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T00:00:00Z","timestamp":1409788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.diabres.2014.08.012","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T10:05:54Z","timestamp":1409911554000},"page":"241-246","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: A retrospective analysis"],"prefix":"10.1016","volume":"106","author":[{"given":"Eiichi","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Amaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2014.08.012_bib0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","article-title":"End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions","volume":"34","author":"Ritz","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2014.08.012_bib0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ajkd.2004.10.019","article-title":"Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy","volume":"45","author":"Atkins","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2014.08.012_bib0015","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","article-title":"Mortality caused by sepsis in patients with end-stage renal disease compared with the general population","volume":"58","author":"Sarnak","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2014.08.012_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jama.1994.03510250050033","article-title":"Effect of age and diagnosis on survival of older patients beginning chronic dialysis","volume":"271","author":"Byrne","year":"1994","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2014.08.012_bib0025","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1046\/j.1523-1755.2001.00020.x","article-title":"Diabetic nephropathy: prevention and treatment","volume":"60","author":"Parving","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2014.08.012_bib0030","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJMcp011773","article-title":"Nephropathy in patients with type 2 diabetes","volume":"346","author":"Remuzzi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2014.08.012_bib0035","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2014.08.012_bib0040","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"RENAAL Study Investigators: effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2014.08.012_bib0045","first-page":"257","article-title":"Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?","volume":"9","author":"Muso","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2014.08.012_bib0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1159\/000045113","article-title":"LDL-apheresis for diabetic nephropathy: a possible new tool","volume":"79","author":"Kobayashi","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.diabres.2014.08.012_bib0055","first-page":"209","article-title":"Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells","volume":"43","author":"Cattin","year":"1997","journal-title":"ASAIO J"},{"key":"10.1016\/j.diabres.2014.08.012_bib0060","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.CIR.96.5.1381","article-title":"Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia","volume":"96","author":"Sampietro","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2014.08.012_bib0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000071884","article-title":"Effect of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans","volume":"26","author":"Nakamura","year":"2003","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.diabres.2014.08.012_bib0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jca.20033","article-title":"LDL-apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effects","volume":"20","author":"Kobayashi","year":"2005","journal-title":"J Clin Apher"},{"key":"10.1016\/j.diabres.2014.08.012_bib0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cyto.2011.04.003","article-title":"Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresis","volume":"55","author":"Stefanutti","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.diabres.2014.08.012_bib0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cyto.2011.08.027","article-title":"Lipid and low-density-lipoprotein apheresis: effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia","volume":"56","author":"Stefanutti","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.diabres.2014.08.012_bib0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.ajkd.2004.09.013","article-title":"Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy","volume":"45","author":"Nakamura","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2014.08.012_bib0090","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1172\/JCI119163","article-title":"Podocyte loss and progressive glomerular injury in type II diabetes","volume":"99","author":"Pagtalunan","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2014.08.012_bib0095","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2337\/diacare.23.8.1168","article-title":"Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy","volume":"23","author":"Nakamura","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.08.012_bib0100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000046097","article-title":"Urinary podocytes in primary focal segmental glomerulosclerosis","volume":"89","author":"Hara","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.diabres.2014.08.012_bib0105","series-title":"Heptinstall's pathology of the kidney","year":"2006"},{"key":"10.1016\/j.diabres.2014.08.012_bib0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.diabres.2014.08.012_bib0120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1526-0968.2002.00458.x","article-title":"A case of nephrotic syndrome due to lupus nephritis which was controlled with low-density lipoprotein apheresis","volume":"6","author":"Kamijo","year":"2002","journal-title":"Ther Apheresis"},{"key":"10.1016\/j.diabres.2014.08.012_bib0125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0272-6386(12)70171-3","article-title":"Cellular mechanisms of lipid injury in the glomerulus","volume":"22","author":"Schlondoff","year":"1993","journal-title":"Am J Kidney Dis"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822714003751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822714003751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T03:00:58Z","timestamp":1538276458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822714003751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0168822714003751"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2014.08.012","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2014.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}